Abstract Anti-aging medicine has become a popular topic in recent years. It considers biological aging a revertible process that physiologically serves no posi tive function. Different technologies in systemic delivery and various strategies that characterize and optimize the performance of systemic delivery have been covered in this book. These technologies are essential for the establishment of a technical platform for interventive biogerontology. As the last chapter of this book, we would like to highlight some directions for future applications of systemic drug delivery in anti-aging medicine. We believe that biological aging and aging-related diseases are strongly associated with genetics/genomics and are pre-programmed. Several interventive approaches such as cellular/tissue reprogramming, microbiota supple mentation, seno-therapeutics and pharmacological targeting will be discussed in this chapter
balistreri cr (2020). New Directions for Use of Systemic Drug Delivery in Anti-aging Medicine. In Wing-Fu Lai (a cura di), Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications (pp. 495-511). Wing-Fu Lai [10.1007/978-3-030-54490-4_21].
New Directions for Use of Systemic Drug Delivery in Anti-aging Medicine
balistreri cr
2020-05-12
Abstract
Abstract Anti-aging medicine has become a popular topic in recent years. It considers biological aging a revertible process that physiologically serves no posi tive function. Different technologies in systemic delivery and various strategies that characterize and optimize the performance of systemic delivery have been covered in this book. These technologies are essential for the establishment of a technical platform for interventive biogerontology. As the last chapter of this book, we would like to highlight some directions for future applications of systemic drug delivery in anti-aging medicine. We believe that biological aging and aging-related diseases are strongly associated with genetics/genomics and are pre-programmed. Several interventive approaches such as cellular/tissue reprogramming, microbiota supple mentation, seno-therapeutics and pharmacological targeting will be discussed in this chapter
| File | Dimensione | Formato | |
|---|---|---|---|
|
978-3-030-54490-4_21 chapter 2020.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
476.03 kB
Formato
Adobe PDF
|
476.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
